You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Octreotide

Showing 26 - 50 of 391
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Liver Transplantation, Renal Failure Trial (Octreotide Acetate, Placebo)

Not yet recruiting
  • Liver Transplantation
  • Renal Failure
  • Octreotide Acetate
  • Placebo
  • (no location specified)
Jun 25, 2021

Esophageal Varices, Liver Cirrhoses, Bleeding Esophageal Varices Trial in United States (Octreotide)

Recruiting
  • Esophageal Varices
  • +3 more
  • Octreotide
  • Jacksonville, Florida
  • +7 more
Dec 20, 2021

Pancreatic Surgery Trial in Paris (Somatostatin, Octreotide)

Completed
  • Pancreatic Surgery
  • Paris, France
  • +1 more
Apr 30, 2021

Renal Impairment in Hepatorenal Syndrome Trial in Cairo (norepinephrine versus midodrine & octreotide)

Completed
  • Renal Impairment in Hepatorenal Syndrome
  • norepinephrine versus midodrine & octreotide
  • Cairo, Egypt
    NHTMRI
Feb 21, 2021

Adult Medulloblastoma, Childhood Medulloblastoma, Neuroblastoma Trial in Iowa City (drug, procedure, radiation)

Completed
Has Results
  • Adult Medulloblastoma
  • +4 more
  • gallium Ga 68-edotreotide
  • +4 more
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Aug 26, 2021

Carcinoid Tumor of the Small Bowel, Neuroendocrine Tumour Trial in Worldwide (Octreotide LAR, 177Lu-DOTA0-Tyr3-Octreotate)

Completed
Has Results
  • Carcinoid Tumor of the Small Bowel
  • Neuroendocrine Tumour
  • Los Angeles, California
  • +38 more
Mar 10, 2022

Neuroendocrine Tumors, Carcinoid Tumors, Neuroblastoma Trial in Iowa City (68Ga-DOTATOC PET/CT)

Completed
Has Results
  • Neuroendocrine Tumors
  • +3 more
  • 68Ga-DOTATOC PET/CT
  • Iowa City, Iowa
    University of Iowa Health Care
Jul 24, 2021

Tachycardia, Chronic Orthostatic Intolerance Trial in Nashville (drug, other, dietary supplement, radiation, procedure, device)

Active, not recruiting
  • Tachycardia
  • Chronic Orthostatic Intolerance
  • Nashville, Tennessee
    Vanderbilt University Autonomic Dysfunction Center
Sep 12, 2022

Carcinoid Tumors Trial in Boston (Ramucirumab, Somatostatin Analog)

Active, not recruiting
  • Carcinoid Tumors
  • Boston, Massachusetts
  • +1 more
Apr 14, 2022

Insulin Resistance, Prediabetic State, Hyperinsulinemia Trial in New York (drug, other, dietary supplement, device)

Recruiting
  • Insulin Resistance
  • +4 more
  • Insulin human
  • +8 more
  • New York, New York
    Columbia University Irving Medical Center
Feb 2, 2023

Vascular Stiffness, Insulin Sensitivity Trial in Charlottesville (Octreotide, Insulin, Dextrose 20% solution)

Completed
Has Results
  • Vascular Stiffness
  • Insulin Sensitivity
  • Octreotide
  • +2 more
  • Charlottesville, Virginia
    University of Virginia
Apr 20, 2022

Renal Function Disorder, Acute Variceal Bleeding Trial in China (Terlipressin, Octreotide)

Recruiting
  • Renal Function Disorder
  • Acute Variceal Bleeding
  • Hefei, Anhui, China
  • +9 more
Aug 16, 2021

Neuroendocrine Tumors Trial in Houston (AlphaMedix)

Recruiting
  • Neuroendocrine Tumors
  • Houston, Texas
    Excel Diagnostics and Nuclear Oncology Center
Jan 5, 2022

Neuroendocrine Tumors Trial in Iowa City ([90]Y-DOTATOC)

Suspended
  • Neuroendocrine Tumors
  • Iowa City, Iowa
    The Holden Comprehensive Cancer Center
Mar 8, 2022

Octreotide, Sputum Trial in Danbury (Octreotide)

Completed
Has Results
  • Octreotide
  • Sputum
  • Octreotide
  • Danbury, Connecticut
    Danbury Hospital
Sep 16, 2020

Pancreatic Cancer Trial in Liverpool (Blumgart Anastomosis, Cattell-Warren Anastomosis, Octreotide)

Active, not recruiting
  • Pancreatic Cancer
  • Blumgart Anastomosis
  • +2 more
  • Liverpool, Merseyside, United Kingdom
    Royal Liverpool University Hospital
Dec 8, 2021

Gastroenteropancreatic Neuroendocrine Tumor Trial in Belgium, Netherlands (Somatostatin analog)

Not yet recruiting
  • Gastroenteropancreatic Neuroendocrine Tumor
  • Somatostatin analog
  • Brasschaat, Antwerp, Belgium
  • +19 more
Jan 31, 2023

Acromegaly Trial in Worldwide (CAM2029 (octreotide subcutaneous depot), Matching )

Active, not recruiting
  • Acromegaly
  • CAM2029 (octreotide subcutaneous depot)
  • Matching placebo
  • Los Angeles, California
  • +62 more
Dec 9, 2022

Neuroendocrine Tumors Trial in Napoli (Octreotide Acetate)

Completed
  • Neuroendocrine Tumors
  • Octreotide Acetate
  • Napoli, Italy
    Istitute Nazionale Tumori - Fondazione G. Pascale
Sep 9, 2020

Gastrointestinal Nutrient Transit and Enteroendocrine Function

Completed
  • Esophageal Cancer
  • +5 more
  • Octreotide Acetate
  • +4 more
  • Dublin, Ireland
  • +1 more
Aug 12, 2021

Adenoma Trial in Orlando (octreotide, No Octreotide)

Terminated
  • Adenoma
  • octreotide
  • No Octreotide
  • Orlando, Florida
    Florida Hospital
Jul 15, 2020

GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease Trial in United States

Recruiting
  • GEP-NET
  • +6 more
  • Duarte, California
  • +3 more
Jul 28, 2022

Hepato-Renal Syndrome Trial in Cairo (Midodrine/Octreotide, Nor-epinephrine)

Completed
  • Hepato-Renal Syndrome
  • Cairo, Egypt
    The National Hepatology and Tropical Research medicine institute
Aug 18, 2020

Meningioma, Metastatic Well Differentiated Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1 Trial in Houston (Computed

Terminated
  • Meningioma
  • +5 more
  • Computed Tomography
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 11, 2021

Neuroendocrine Tumor Trial in Houston (AlphaMedix)

Recruiting
  • Neuroendocrine Tumor
  • Houston, Texas
  • +1 more
Aug 17, 2021